Unknown

Dataset Information

0

Associations between resting-state functional connectivity and treatment response in a randomized clinical trial for posttraumatic stress disorder.


ABSTRACT:

Background

Alterations in resting-state functional connectivity (rsFC) have been reported in posttraumatic stress disorder (PTSD). Here, we examined pre- and post-treatment rsFC during a randomized clinical trial to characterize alterations and examine predictors of treatment response.

Methods

Sixty-four combat veterans with PTSD were randomly assigned to prolonged exposure (PE) plus placebo, sertraline plus enhanced medication management, or PE plus sertraline. Symptom assessment and resting-state functional magnetic resonance imaging (fMRI) scans occurred before and after treatment. Twenty-nine trauma-exposed combat veterans without PTSD served as a control group at intake. Seed-based and region of interest (ROI)-to-ROI connectivities, as well as an exploratory connectome-based approach were used to analyze rsFC patterns. Based on previously reported findings, analyses focused on Salience Network (SN) and Default-Mode Network (DMN).

Results

At intake, patients with PTSD showed greater DMN-dorsal attention network (DAN) connectivity (between ventromedial prefrontal cortex and superior parietal lobule; family-wise error corrected p = .011), greater SN-DAN connectivity (between insula and middle frontal gyrus; corrected p = .003), and a negative correlation between re-experiencing symptoms and within-DMN connectivity (between posterior cingulate cortex (PCC) and middle temporal gyrus; corrected p < .001). We also found preliminary evidence for associations between rsFC and treatment response. Specifically, high responders (≥50% PTSD symptom improvement), compared with low responders, had greater SN-DMN segregation (i.e., less pre-treatment amygdala-PCC connectivity; p = .011) and lower pre-treatment global centrality (p = .042).

Conclusions

Our findings suggest neural abnormalities in PTSD and may inform future research examining neural biomarkers of PTSD treatment response.

SUBMITTER: Sheynin J 

PROVIDER: S-EPMC7722156 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6447465 | biostudies-literature
| S-EPMC6488394 | biostudies-literature
| S-EPMC3870774 | biostudies-literature
| S-EPMC7483700 | biostudies-literature
| S-EPMC8433283 | biostudies-literature
| S-EPMC4184309 | biostudies-literature
| S-EPMC7035375 | biostudies-literature
| S-EPMC4983452 | biostudies-literature
| S-EPMC5842755 | biostudies-literature
| S-EPMC6474202 | biostudies-literature